Journal of the Neurological Sciences
Volume 283, Issue 1 , Pages 207-210 , 15 August 2009

Treatment of dementia and cognitive impairment: What can we learn from the Cochrane Library

  • Dániel Bereczki

      Affiliations

    • Department of Neurology, Semmelweis University, Budapest, Hungary
    • Corresponding Author InformationCorresponding author. Department of Neurology, Semmelweis University, Budapest, Balassa u. 6, H-1083, Hungary. Tel.: +36 1 210 0337; fax: +36 1 210 1368.
    • ,
  • Szabolcs Szatmári

      Affiliations

    • Department of Neurology, University of Medicine and Pharmacy, Targu Mures, Romania

References 

  1. World Health Organization. International Classification of Diseases — ICD-10, Version 2007. URL: http://www.who.int/classifications/apps/icd/icd10online. Accessed: January 2, 2008.
  2. Launer LJ, Andersen K, Dewey ME, Letenneur L, Ott A, Amaducci LA, et al. Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. EURODEM Incidence Research Group and Work Groups. European Studies of Dementia. Neurology. 1999;52:78–84
  3. Kalache A, Keller I. The greying world: a challenge for the twenty-first century. Sci Prog. 2000;83(Pt 1):33–54
  4. United States National Library of Medicine. PubMed. URL: http://www.ncbi.nlm.nih.gov/sites/entrez/. Accessed: January 2, 2008.
  5. Baskys A, Hou AC. Vascular dementia: pharmacological treatment approaches and perspectives. Clin Interv Aging. 2007;2:327–335
  6. Omerovic M, Hampel H, Teipel SJ, Buerger K. Pharmacological treatment of Alzheimer's dementia: state of the art and current dilemmas. World J Biol Psychiatry. 2008;9:69–75
  7. Sink KM, Holden KF, Yaffe K. Pharmacological treatment of neuropsychiatric symptoms of dementia: a review of the evidence. JAMA. 2005;293:596–608
  8. Waldemar G, Dubois B, Emre M, Georges J, McKeith IG, Rossor M, et al Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline. Eur J Neurol. 2007;14:e1–e26
  9. Szatmári S, Whitehouse PJ. Vinpocetine for cognitive impairment and dementia. Cochrane Database Syst Rev. 2003;(1):Art. No.: CD003119
  10. Szatmári S, Bereczki D. Procaine treatments for cognition and dementia. Cochrane Database of Systematic Reviews 2008, Issue 4. Art. No.: CD005993, doi:10.1002/14651858.CD005993.pub2.
  11. Yan H, Li L, Tang XC. Treating senile dementia with traditional Chinese medicine. Clin Interv Aging. 2007;2:201–208
  12. Huang Y, Lai XS, Tang AW. Comparative study of the specificities of needling acupoints DU20, DU26 and HT7 in intervening vascular dementia in different areas in the brain on the basis of scale assessment and cerebral functional imaging. Chin J Integr Med. 2007;13:103–108
  13. Purandare N, Swarbrick C, Fischer A, Burns A. Cholinesterase inhibitors for Alzheimer's disease: variations in clinical practice in the north-west of England. Int J Geriatr Psychiatry. 2006;21:961–964
  14. Ramassamy C, Longpré F, Christen Y. Ginkgo biloba extract (EGb 761) in Alzheimer's disease: is there any evidence?. Curr Alzheimer Res. 2007;4:253–262
  15. Dos Santos-Neto LL, de Vilhena Toledo MA, Medeiros-Souza P, de Souza GA. The use of herbal medicine in Alzheimer's disease—a systematic review. Evid. Based Complement. Altern. Med. 2006;3:441–445
  16. Kennedy DO, Scholey AB. The psychopharmacology of European herbs with cognition-enhancing properties. Curr Pharm Des. 2006;12:4613–4623
  17. Cochrane AL. 1931–1971: a critical review, with particular reference to the medical profession. In: Medicines for the year 2000. London: Office of Health Economics; 1979;p. 1–11
  18. The Cochrane Library, Issue 3. Chichester: Wiley; 2008;
  19. McShane R, Collins H. Cochrane Dementia and Cognitive Improvement Group. About The Cochrane Collaboration (Cochrane Review Groups (CRGs)). 2008;Issue 2. Art. No.: DEMENTIA
  20. In:  Higgins JPT,  Green S editor. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Collaboration. 2008;Available from www.cochrane-handbook.org
  21. Malouf R, Birks J. Donepezil for vascular cognitive impairment. Cochrane Database Syst Rev. 2004;(1):Art. No.: CD004395
  22. Craig D, Birks J. Rivastigmine for vascular cognitive impairment. Cochrane Database Syst Rev. 2004;(2):Art. No.: CD004744
  23. McShane R, Areosa Sasstre A, Minakaran N. Memantine for dementia. Cochrane Database Syst Rev. 2006;(2):Art. No.: CD003154
  24. Tabet N, Feldman H. Indomethacin for Alzheimer's disease. Cochrane Database Syst Rev. 2002;(2):Art. No.: CD003673
  25. Jones R, Laake K, Oeksengaard AR. D-cycloserine for Alzheimer's disease. Cochrane Database Syst Rev. 2002;(2):Art. No.: CD003153
  26. Scott HD, Laake K. Statins for the prevention of Alzheimer's disease. Cochrane Database Syst Rev. 2001;(3):Art. No.: CD003160
  27. Birks J, Grimley Evans J. Ginkgo biloba for cognitive impairment and dementia. Cochrane Database Syst Rev. 2007;(2):Art. No.: CD003120

PII: S0022-510X(09)00438-9

doi: 10.1016/j.jns.2009.02.351

Journal of the Neurological Sciences
Volume 283, Issue 1 , Pages 207-210 , 15 August 2009

Article Tools

* Image Usage & Resolution